Estrogen: effects and actions in osteoporosis.

Suppr

超能文献

作者信息

Lindsay R, Cosman F, Nieves J

机构信息

Helen Hayes Hospital, Regional Bone Center, West Haverstraw, New York.

出版信息

Osteoporos Int. 1993;3 Suppl 1:150-2. doi: 10.1007/BF01621892.

DOI:10.1007/BF01621892

PMID:8461545

Abstract

摘要

相似文献

Estrogen: effects and actions in osteoporosis.

Osteoporos Int. 1993;3 Suppl 1:150-2. doi: 10.1007/BF01621892.

The role of estrogen in the prevention of osteoporosis.雌激素在预防骨质疏松症中的作用。

Endocrinol Metab Clin North Am. 1998 Jun;27(2):399-409. doi: 10.1016/s0889-8529(05)70012-8.

[Pharmacologic therapy of osteoporosis].

Nihon Rinsho. 1994 Sep;52(9):2367-77.

Sex steroids and osteoporosis. The role of estrogens and androgens.性类固醇与骨质疏松症。雌激素和雄激素的作用。

Clin Lab Med. 2000 Sep;20(3):549-58, vii.

Use of estrogen for prevention and treatment of osteoporosis.雌激素在骨质疏松症预防和治疗中的应用。

Endocrine. 1997 Apr;6(2):207-11. doi: 10.1007/BF02738967.

[Estrogens and selective estrogen receptor modulators in the treatment of osteoporosis].[雌激素及选择性雌激素受体调节剂在骨质疏松症治疗中的应用]

Ann Med Interne (Paris). 2000 Oct;151(6):490-6.

Present status of estrogen treatment for prevention of postmenopausal osteoporosis.雌激素治疗预防绝经后骨质疏松症的现状

Acta Obstet Gynecol Scand Suppl. 1979;88:97-101. doi: 10.3109/00016347909157236.

[Preventive estrogen treatment and osteoporosis in women with bilateral ovariectomy (proceedings)].[预防性雌激素治疗与双侧卵巢切除术后女性的骨质疏松症（会议记录）]

Arch Gynakol. 1977 Jul 29;224(1-4):402-4. doi: 10.1007/BF00679619.

Prevention of postmenopausal bone loss and treatment of osteoporosis.

Semin Reprod Med. 2005 May;23(2):141-8. doi: 10.1055/s-2005-869481.

Estrogen: prevention and treatment of osteoporosis.

Postgrad Med. 1989 Apr;Spec No:7-9; discussion 33-43. doi: 10.1016/b978-012068705-3/50008-5.

引用本文的文献

Induction of osteoporosis with its influence on osteoporotic determinants and their interrelationships in rats by DEXA.DEXA 诱导大鼠骨质疏松及其对骨质疏松决定因素及其相互关系的影响。

Med Sci Monit. 2012 Jun;18(6):BR199-207. doi: 10.12659/msm.882895.

Aromatase inhibitor-associated bone loss: clinical considerations.芳香化酶抑制剂相关的骨质流失：临床考量

Drugs. 2008;68(18):2591-600. doi: 10.2165/0003495-200868180-00005.

本文引用的文献

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.绝经后使用雌激素可降低髋部和前臂下端骨折的风险。

N Engl J Med. 1980 Nov 20;303(21):1195-8. doi: 10.1056/NEJM198011203032102.

Menopausal estrogen therapy and hip fractures.更年期雌激素疗法与髋部骨折

Ann Intern Med. 1981 Jul;95(1):28-31. doi: 10.7326/0003-4819-95-1-28.

An epidemiologic study of hip fracture in postmenopausal women.一项关于绝经后女性髋部骨折的流行病学研究。

Am J Epidemiol. 1982 Jul;116(1):141-8. doi: 10.1093/oxfordjournals.aje.a113388.

The minimum effective dose of estrogen for prevention of postmenopausal bone loss.预防绝经后骨质流失的雌激素最小有效剂量。

Obstet Gynecol. 1984 Jun;63(6):759-63.

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.氟化物/钙疗法对绝经后骨质疏松症患者椎体骨折发生率的影响。与传统疗法的比较。

N Engl J Med. 1982 Feb 25;306(8):446-50. doi: 10.1056/NEJM198202253060802.

Prevention of spinal osteoporosis in oophorectomised women.卵巢切除术后女性脊柱骨质疏松症的预防

Lancet. 1980 Nov 29;2(8205):1151-4. doi: 10.1016/s0140-6736(80)92592-1.

A unified concept of osteoporosis.

Am J Med. 1965 Dec;39(6):877-80. doi: 10.1016/0002-9343(65)90109-9.

Antifracture efficacy of long-term estrogens for osteoporosis.长期使用雌激素治疗骨质疏松症的抗骨折疗效。

Trans Assoc Am Physicians. 1973;86:326-32.

Involutional osteoporosis.老年性骨质疏松症

N Engl J Med. 1986 Jun 26;314(26):1676-86. doi: 10.1056/NEJM198606263142605.

Evidence of estrogen receptors in normal human osteoblast-like cells.正常人成骨样细胞中雌激素受体的证据。

Science. 1988 Jul 1;241(4861):84-6. doi: 10.1126/science.3388021.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验